Imexpharm Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,184,518	8,085,471	7,238,421	3,962,167	4,013,628	5,187,048
Market Cap Growth	7.24%	11.70%	82.69%	-1.28%	-22.62%	38.19%
Enterprise Value	6,922,669	8,062,671	7,072,195	3,840,834	3,828,514	5,172,206
Last Close Price	46650.00	52500.00	46549.81	25168.19	25127.46	31748.83
PE Ratio	23.09	26.56	26.24	14.26	21.83	29.89
Forward PE	19.57	22.97	20.30	11.68	19.00	21.00
PS Ratio	3.00	3.31	3.28	1.99	2.44	4.10
PB Ratio	3.02	3.51	3.32	1.90	2.12	2.89
P/TBV Ratio	3.12	3.62	3.43	1.97	2.20	3.01
P/FCF Ratio	25.86	296.26	60.57	-	14.37	28.50
P/OCF Ratio	24.56	149.26	33.47	-	10.60	22.08
EV/Sales Ratio	2.89	3.30	3.21	1.93	2.33	4.08
EV/EBITDA Ratio	12.18	14.26	13.58	8.28	10.73	17.56
EV/EBIT Ratio	14.85	17.43	17.04	10.08	12.91	22.10
EV/FCF Ratio	24.91	295.42	59.18	-	13.71	28.42
Debt / Equity Ratio	0.08	0.09	0.04	0.02	0.05	0.15
Debt / EBITDA Ratio	0.35	0.38	0.17	0.11	0.27	0.90
Debt / FCF Ratio	0.72	7.80	0.72	-	0.34	1.45
Net Debt / Equity Ratio	-0.11	-0.08	-0.10	-0.07	-0.16	-0.07
Net Debt / EBITDA Ratio	-0.46	-0.33	-0.42	-0.32	-0.83	-0.41
Net Debt / FCF Ratio	-0.94	-6.91	-1.82	1.45	-1.06	-0.66
Asset Turnover	0.84	0.92	0.90	0.85	0.72	0.58
Inventory Turnover	1.92	1.85	1.68	1.78	1.78	1.46
Quick Ratio	2.53	1.96	2.00	1.49	1.62	1.56
Current Ratio	4.55	4.05	4.38	3.92	2.89	2.88
Return on Equity (ROE)	15.42%	15.55%	15.04%	15.06%	12.12%	10.73%
Return on Assets (ROA)	10.16%	10.93%	10.60%	10.20%	8.11%	6.66%
Return on Invested Capital (ROIC)	17.31%	17.72%	16.90%	17.12%	13.89%	10.94%
Return on Capital Employed (ROCE)	18.80%	19.20%	19.00%	18.30%	15.70%	12.40%
Earnings Yield	4.33%	4.32%	4.43%	7.56%	5.57%	3.65%
FCF Yield	3.87%	0.34%	1.65%	-2.60%	6.96%	3.51%
Dividend Yield	1.07%	-	1.07%	1.81%	1.72%	2.04%
Payout Ratio	21.59%	22.05%	21.82%	22.26%	44.74%	52.89%
Buyback Yield / Dilution	3.92%	-	-	0.00%	0.00%	-2.92%
Total Shareholder Return	4.99%	-	1.07%	1.81%	1.72%	-0.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.